Search by Drug Name or NDC
NDC 69683-0202-11 DERMOSCRIBE SEBORRHEIC DERMATITIS 1; 3; 3 g/100g; g/100g; g/100g Details
DERMOSCRIBE SEBORRHEIC DERMATITIS 1; 3; 3 g/100g; g/100g; g/100g
DERMOSCRIBE SEBORRHEIC DERMATITIS is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by DERMOSCRIBE PTY LTD. The primary component is HYDROCORTISONE; SALICYLIC ACID; SULFUR.
Product Information
| NDC | 69683-0202 |
|---|---|
| Product ID | 69683-202_06d42c95-c8cd-7972-e063-6294a90aab3b |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | DERMOSCRIBE SEBORRHEIC DERMATITIS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SULFUR, SALICYLIC ACID, HYDROCORTISONE |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Active Ingredient Strength | 1; 3; 3 |
| Active Ingredient Units | g/100g; g/100g; g/100g |
| Substance Name | HYDROCORTISONE; SALICYLIC ACID; SULFUR |
| Labeler Name | DERMOSCRIBE PTY LTD |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part348 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69683-0202-11 (69683020211)
| NDC Package Code | 69683-202-11 |
|---|---|
| Billing NDC | 69683020211 |
| Package | 60 g in 1 BOTTLE (69683-202-11) |
| Marketing Start Date | 2015-03-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |